ニュース

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
FDA plans to limit COVID vaccine to only high-risk people: What Oklahomans should know
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
FDA expands COVID vaccine warning about heart side effect risk for young males
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a ...
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The ...
FDA’s new approach to covid vaccines could have been way worse
Older adults can continue getting covid boosters, but not everyone who wants them can. You’re reading The Checkup With Dr.
FDA’s new approach raises questions about fall COVID vaccine availability
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
WA vaccine scientists push back against FDA changes around COVID shots
Seattle vaccine experts were confused by the country's apparent new direction around updated COVID-19 shots, which top FDA ...
FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
Opinion | The FDA’s misguided new Covid vaccine policy repeats past mistakes
The Food and Drug Administration is rewriting America’s Covid vaccine playbook, limiting the vaccine based on age and risk ...
Infectious Disease Advisor22 時間
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...